Search
for
Sort by
Research 30 of 1000+
- Permanent alopecia in patients with breast cancer after taxane chemotherapy and adjuvant hormonal therapy: Clinicopathologic findings in a cohort of 10 patients
- Abstract P5-21-05: ERALOP study: Post adjuvant FEC - docetaxel chemotherapy for early breast cancer: Hair regrowth in the real life
- Studies of the components of an oral contraceptive agent in albino rats. II. Progestogenic component and comparison of effects of the components and the combined agent
- Racial Disparities in the Cost of Unplanned Hospitalizations after Breast Reconstruction
- Abstract 1: A Cost-Utility Analysis Comparing Oncoplastic Breast Surgery with Standard Lumpectomy in Large Breasted Women
- Alternative and Complimentary Medicines in the management of Chronic Breast Cancer: A discrete choice cost and clinical case report
- Patient, Oncologist, and Payer Preferences for Adjuvant Endocrine Therapy and CDK4/6 Inhibitor Regimens in Early-Stage Breast Cancer: A Discrete Choice Experiment
- Clinicopathological study of cutaneous adnexal cyst with some unusual presentation
- Real-World Data on Health-Related Quality of Life Assessment in Patients With Breast Cancer Receiving Subcutaneous Trastuzumab
- Non-Contraceptive Benefits of Oral Hormonal Contraceptives
- Rare clinical features of the Ellis van Creveld syndrome: A case report and literature review
- ONCO-NK-TRANSITION-GM1: The Bridge Cancer Therapy Manufacturable by Current Pharmaceutical Industry — 60-80% Cure Rate — $50 per Dose A Complete Transitional Drug from Full N‑K GM Series to Current Pharma Capability
- Robotic surgical systems in plastic and reconstructive surgery
- BH09 Patient experience of off-label Janus kinase inhibitor use for alopecia areata in a cohort of 34 patients from a single UK practitioner: exploring changing trends in healthcare provision and access to drug treatments
- One of These Things Is Not Like the Others: The Idea of Precedence in Health Technology Assessment and Coverage Decisions
- AAPS and PSRC 2016 Abstract Supplement
- Putting it all together: How do primary care physicians interpret and use the results of prevention trials?
- Expanding the Availability of Scalp Cooling to All Patients at Risk of Chemotherapy-Induced Alopecia
- The financial burden of scalp cooling therapy: A nonprofit organization data analysis
- Sulfotransferases, sulfatases and formylglycine-generating enzymes: a sulfation fascination
- Aesthetic Plastic Surgery National Databank Statistics 2022
- Prevention and Treatment of Chemotherapy-Induced Alopecia: What Is Available and What Is Coming?
- Emerging 3D bioprinting applications in plastic surgery
- Aromatase inhibitor therapy and hair loss among breast cancer survivors
- Finasteride and Male Breast Cancer: Does the MHRA Report Show a Link?
- Multiple Benign Epidermal Inclusion Cysts Clinically Misdiagnosed as Rhinophyma: A Case Report
- Persistent Alopecia in a Breast Cancer Patient Following Taxane Chemotherapy and Adjuvant Endocrine Therapy: Case Report and Review of Post-treatment Hair Loss in Oncology Patients with Breast Cancer
- Permanent scalp alopecia related to breast cancer chemotherapy by sequential fluorouracil/epirubicin/cyclophosphamide (FEC) and docetaxel: a prospective study of 20 patients
- Patient-Controlled Expansion: Applying a New Technique to Breast Reconstruction
- Management of hair loss associated with endocrine therapy in patients with breast cancer: an overview